Release Date: 30/10/17 09:44 Summary: September 2017 Quarterly Report Price Sensitive: Yes Download Document 1.45MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%